Skip to main content
Erschienen in: Calcified Tissue International 6/2017

12.09.2017 | Original Research

Free Fatty Acid Receptor 4 Mediates the Beneficial Effects of n-3 Fatty Acids on Body Composition in Mice

verfasst von: Han Jin Cho, Seong Hee Ahn, Young-Sun Lee, Seung Hun Lee, Dong-Soon Im, Inki Kim, Jung-Min Koh, Sungsub Kim, Beom-Jun Kim

Erschienen in: Calcified Tissue International | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

As populations continue to age worldwide, sarcopenic obesity has heightened interest due to its medical importance. Although much evidence now indicates that n-3 fatty acids (FAs) may have beneficial effects on body composition including fat and muscle, their exact mechanisms have not yet been elucidated. Because free FA receptor 4 (FFA4) has been reported to be a receptor for n-3 FAs, we hypothesized that the protective role of n-3 FAs on body composition could be mediated by FFA4. To test this possibility, we generated mice overexpressing n-3 FAs but lacking FFA4 by crossing fat-1 transgenic (fat-1 Tg+) and FFA4 knockout (Ffar4 −/−) mice. Because fat-1 Tg+ mice, in which n-6 is endogenously converted into n-3 FAs, contain high n-3 FA levels, they could be a good animal model for studying the effects of n-3 FAs in vivo. Male and female littermates were included in high-fat-diet- (HFD) and ovariectomy-induced models, respectively. In the HFD model, male fat-1 Tg+ mice had a lower percentage of fat mass and a higher percentage of lean mass than their wild-type littermates only when they had the Ffar4 +/+ not the Ffar4 −/− background. Female fat-1 Tg+ mice showed less increase of fat mass percentage and less decrease of lean mass percentage after ovariectomy than wild-type littermates. However, these effects on body composition were attenuated in the Ffar4 −/− background. Taken together, our results indicate that the beneficial effects of n-3 FAs on body composition were mediated by FFA4 and thus suggest that FFA4 may be a potential therapeutic target for modulating sarcopenic obesity.
Literatur
3.
Zurück zum Zitat Maltais ML, Desroches J, Dionne IJ (2009) Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact 9:186–197PubMed Maltais ML, Desroches J, Dionne IJ (2009) Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact 9:186–197PubMed
5.
Zurück zum Zitat Schrauwen P, Westerterp KR (2000) The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84:417–427CrossRefPubMed Schrauwen P, Westerterp KR (2000) The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84:417–427CrossRefPubMed
6.
Zurück zum Zitat Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12:1995–2004. doi:10.1038/oby.2004.250 CrossRefPubMed Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12:1995–2004. doi:10.​1038/​oby.​2004.​250 CrossRefPubMed
8.
Zurück zum Zitat Dominguez LJ, Barbagallo M (2007) The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2:183–189CrossRefPubMed Dominguez LJ, Barbagallo M (2007) The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2:183–189CrossRefPubMed
9.
Zurück zum Zitat Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B (2009) Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr 89:1895–1900. doi:10.3945/ajcn.2008.26950 CrossRefPubMed Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B (2009) Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr 89:1895–1900. doi:10.​3945/​ajcn.​2008.​26950 CrossRefPubMed
10.
Zurück zum Zitat Stenholm S, Alley D, Bandinelli S, Griswold ME, Koskinen S, Rantanen T, Guralnik JM, Ferrucci L (2009) The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int J Obes (Lond) 33:635–644. doi:10.1038/ijo.2009.62 CrossRef Stenholm S, Alley D, Bandinelli S, Griswold ME, Koskinen S, Rantanen T, Guralnik JM, Ferrucci L (2009) The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int J Obes (Lond) 33:635–644. doi:10.​1038/​ijo.​2009.​62 CrossRef
13.
Zurück zum Zitat Lorente-Cebrian S, Costa AG, Navas-Carretero S, Zabala M, Martinez JA, Moreno-Aliaga MJ (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 69:633–651. doi:10.1007/s13105-013-0265-4 CrossRefPubMed Lorente-Cebrian S, Costa AG, Navas-Carretero S, Zabala M, Martinez JA, Moreno-Aliaga MJ (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 69:633–651. doi:10.​1007/​s13105-013-0265-4 CrossRefPubMed
15.
Zurück zum Zitat Huang F, Wei H, Luo H, Jiang S, Peng J (2011) EPA inhibits the inhibitor of kappaBalpha (IkappaBalpha)/NF-kappaB/muscle RING finger 1 pathway in C2C12 myotubes in a PPARgamma-dependent manner. Br J Nutr 105:348–356. doi:10.1017/S0007114510003703 CrossRefPubMed Huang F, Wei H, Luo H, Jiang S, Peng J (2011) EPA inhibits the inhibitor of kappaBalpha (IkappaBalpha)/NF-kappaB/muscle RING finger 1 pathway in C2C12 myotubes in a PPARgamma-dependent manner. Br J Nutr 105:348–356. doi:10.​1017/​S000711451000370​3 CrossRefPubMed
17.
18.
Zurück zum Zitat Apolinario LM, De Carvalho SC, Santo Neto H, Marques MJ (2015) Long-term therapy with omega-3 ameliorates myonecrosis and benefits skeletal muscle regeneration in Mdx mice. Anat Rec (Hoboken) 298:1589–1596. doi:10.1002/ar.23177 CrossRef Apolinario LM, De Carvalho SC, Santo Neto H, Marques MJ (2015) Long-term therapy with omega-3 ameliorates myonecrosis and benefits skeletal muscle regeneration in Mdx mice. Anat Rec (Hoboken) 298:1589–1596. doi:10.​1002/​ar.​23177 CrossRef
19.
20.
21.
Zurück zum Zitat Simopoulos AP (1998) Redefining dietary reference values and food safety. World Rev Nutr Diet 83:219–222CrossRefPubMed Simopoulos AP (1998) Redefining dietary reference values and food safety. World Rev Nutr Diet 83:219–222CrossRefPubMed
23.
Zurück zum Zitat Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90–94. doi:10.1038/nm1168 CrossRefPubMed Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90–94. doi:10.​1038/​nm1168 CrossRefPubMed
25.
Zurück zum Zitat Bollheimer LC, Buettner R, Pongratz G, Brunner-Ploss R, Hechtl C, Banas M, Singler K, Hamer OW, Stroszczynski C, Sieber CC, Fellner C (2012) Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents. Biogerontology 13:609–620. doi:10.1007/s10522-012-9405-4 CrossRefPubMed Bollheimer LC, Buettner R, Pongratz G, Brunner-Ploss R, Hechtl C, Banas M, Singler K, Hamer OW, Stroszczynski C, Sieber CC, Fellner C (2012) Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents. Biogerontology 13:609–620. doi:10.​1007/​s10522-012-9405-4 CrossRefPubMed
27.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423. doi:10.1093/ageing/afq034 CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423. doi:10.​1093/​ageing/​afq034 CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Korner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Levy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483:350–354. doi:10.1038/nature10798 CrossRefPubMed Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Korner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Levy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483:350–354. doi:10.​1038/​nature10798 CrossRefPubMed
34.
Zurück zum Zitat Ahn SH, Park SY, Baek JE, Lee SY, Baek WY, Lee SY, Lee YS, Yoo HJ, Kim H, Lee SH, Im DS, Lee SK, Kim BJ, Koh JM (2016) Free fatty acid receptor 4 (GPR120) stimulates bone formation and suppresses bone resorption in the presence of elevated n-3 fatty acid levels. Endocrinology 157:2621–2635. doi:10.1210/en.2015-1855 CrossRefPubMed Ahn SH, Park SY, Baek JE, Lee SY, Baek WY, Lee SY, Lee YS, Yoo HJ, Kim H, Lee SH, Im DS, Lee SK, Kim BJ, Koh JM (2016) Free fatty acid receptor 4 (GPR120) stimulates bone formation and suppresses bone resorption in the presence of elevated n-3 fatty acid levels. Endocrinology 157:2621–2635. doi:10.​1210/​en.​2015-1855 CrossRefPubMed
Metadaten
Titel
Free Fatty Acid Receptor 4 Mediates the Beneficial Effects of n-3 Fatty Acids on Body Composition in Mice
verfasst von
Han Jin Cho
Seong Hee Ahn
Young-Sun Lee
Seung Hun Lee
Dong-Soon Im
Inki Kim
Jung-Min Koh
Sungsub Kim
Beom-Jun Kim
Publikationsdatum
12.09.2017
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 6/2017
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0323-y

Weitere Artikel der Ausgabe 6/2017

Calcified Tissue International 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.